This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Industry-specific guidance, benchmarking on standards and practical expertise to minimize uncertainty and drive corporate growth.

The Life Sciences Market - Biotech IPOs & the SPAC Boom | Interview with RSM

Share this article

In this exclusive interview, Chris Martin, Life Sciences Technical Accounting Consulting Leader at RSM US LLP, discusses the life sciences market, focusing on why biotech is the dominant sector within the life sciences for IPOs and capital raised. He also explores the SPAC boom and what life as a public company looks like after an IPO. Martin was speaking to Sharon Langan, Global Practice Leader for Informa Connect Life Sciences Global Finance & Accounting. Watch the full interview below (or here).

Is going public in your future? Download the RSM guide to going public.


Share this article